Skip to main content
Quest Diagnostics

Performance of the LIAISON PLEX Gram-Negative Blood Culture Assay for Identifying Bacterial Pathogens and Resistance Genes in Blood Cultures

Performance of the LIAISON PLEX Gram-Negative Blood Culture Assay for Identifying Bacterial Pathogens and Resistance Genes in Blood Cultures

Authors: Dhiman N, Emery CL, Chow S-K, Ho D, Granato P, Bernier B, Farhang J

Citation: J Clin Microbiol. 2026 May 22:e0001826. doi: 10.1128/jcm.00018-26. Online ahead of print.

Specialties: Infectious diseasee

Related content

Publication
Performance of the LIAISON PLEX Gram-Positive Blood Culture Assay for Identifying Bacterial Pathogens and Resistance Genes in Blood Cultures
Publication
Analytical Validation of Blood-Derived Tumor Mutation Burden (bTMB) Assays: A Joint Consensus Recommendation of the BLOODPAC bTMB Analytical Validation Working Group
Publication
First Description of the Performance of the VITEK MITUBE Device Used With MALDI-TOF Mass Spectrometry to Achieve Identification of Gram-Negative Bacteria Directly From Positive Blood Culture Broth
Publication
Multicenter Evaluation of the eQUANT System for Use With Disk Diffusion AST of Gram-Negative Bacteria Directly From Positive Blood Cultures

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2026 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.